메뉴 건너뛰기
American Journal of Managed Care
Volumn 4, Issue 1 SUPPL., 1998, Pages
Antipsychotic medications: Present and future
Author keywords

[No Author keywords available]
Indexed keywords

NEUROLEPTIC AGENT;
EID: 0031856201     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)
References (3)
  • 1
    • 0027264874 scopus 로고
    • Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medication
    • Glazer WM, Morgenstern H. Doucette JT. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medication. J Clin Psychiatry 1993;54:133-139.
    • (1993) J Clin Psychiatry , vol.54 , pp. 133-139
    • Glazer, W.M.1    Morgenstern, H.2    Doucette, J.T.3
  • 2
    • 0021206412 scopus 로고
    • Incidence of tardive dyskinesia: Five year data from a prospective study
    • Kane JM, Woerner M, Weinhold P, et al. Incidence of tardive dyskinesia: Five year data from a prospective study. Psychopharmacol Bull 1994;20:39-40.
    • (1994) Psychopharmacol Bull , vol.20 , pp. 39-40
    • Kane, J.M.1    Woerner, M.2    Weinhold, P.3
  • 3
    • 13144284088 scopus 로고    scopus 로고
    • Medical resource use and socioeconomic outcomes for olanzapine compared with haloperidol in the treatment of schizophrenia and other psychotic disorders
    • November, Phoenix, AZ
    • Hamilton SH, Genduso L, Revicki DA, Johnstone BM. Medical resource use and socioeconomic outcomes for olanzapine compared with haloperidol in the treatment of schizophrenia and other psychotic disorders. Presented at the 1997 annual meeting of the American College of Clinical Pharmacy. November, 1997; Phoenix, AZ.
    • (1997) 1997 Annual Meeting of the American College of Clinical Pharmacy
    • Hamilton, S.H.1    Genduso, L.2    Revicki, D.A.3    Johnstone, B.M.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.